^
Association details:
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Rectal cancer: Systemic therapy for advanced or metastatic disease…Trastuzumab + Pertuzumab...(HER2-amplified and RAS and BRAF WT)